Donepezil–tacrine hybrid related derivatives as new dual binding site inhibitors of AChE
D. A. Alonso(Neuron BioPharma (Spain)), Ana Martı́nez(Consejo Superior de Investigaciones Científicas), Esther García‐Palomero(Universitat de Barcelona), Axel Bidon‐Chanal(Universitat de Barcelona), Miguel Medina(Baptist Hospital of Miami), Laura Rubio(Pontificia Universidad Católica Madre y Maestra), F. Javier Luque(Universidad Complutense de Madrid), Ana Castro(Instituto de Química Médica), Isabel Dorronsoro(Instituto de Química Médica), Maria del Monte(Neuron BioPharma (Spain)), Patricia L. A. Muñoz-Muñoz(Neuron BioPharma (Spain)), Modesto Orozco(Institute for Research in Biomedicine)
Cited by 157
Related Papers
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Non-coding recurrent mutations in chronic lymphocytic leukaemia
|Nature|2015|851
Molecular dynamics simulations: advances and applications
|Advances and Applications in Bioinformatics and Chemistry|2015|812
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469